Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04407754 · ClinicalTrials.gov registry record · NA

Myo-Inositol for Infertility in PCOS

A NA study of Polycystic Ovary Syndrome, sponsored by University of Oklahoma.

Recruiting
Registry status
NA
Development phase
168
Enrollment target
1
Study location

NCT04407754 is a NA study of Polycystic Ovary Syndrome that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 168 participants, below the 17,252-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04407754, a NA study of Polycystic Ovary Syndrome, is actively recruiting participants, sponsored by University of Oklahoma.

RECRUITING
Registry status
NA
Development phase
168 participants
Enrollment target
1
Study location

Study Summary

This will be a prospective, double-blind randomized clinical trial of letrozole and placebo versus letrozole and inositols for up to 5 treatment cycles of ovulation induction or until pregnancy is achieved. All participants and members of the research team will be blinded to the treatment arms. Placebo and inositol supplement will be packaged to appear the same, tested, and packaged by a commercial supply company. The inositols will be a 40:1 blend of myo-inositol and D-chiro inositol.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Inositol supplement
  • DIETARY_SUPPLEMENT Placebo supplement

Study Locations (1)

Oklahoma

  • OUHSC Reproductive Medicine Clinic - Oklahoma City

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2022-02-07
Est. Completion 2026-02
Phase NA

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT04407754

The ClinicalTrials.gov registry entry for NCT04407754 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 17,252-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (99% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Polycystic Ovary Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Inositol supplement is the first listed.

NCT04407754 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT04407754 about?

NCT04407754 is a clinical study titled "Myo-Inositol for Infertility in PCOS". This will be a prospective, double-blind randomized clinical trial of letrozole and placebo versus letrozole and inositols for up to 5 treatment cycles of ovulation induction or until pregnancy is achieved. All participants and members of the research team will be blinded to the treatment arms. Plac...

What is the current status of trial NCT04407754?

This trial is currently recruiting. It is a NA study. The enrollment target is 168 participants. The study started on 2022-02-07. Estimated completion is 2026-02.

What conditions does trial NCT04407754 study?

This clinical trial studies the following conditions: Polycystic Ovary Syndrome.

What interventions are being tested in trial NCT04407754?

The interventions under investigation include: Inositol supplement (DIETARY_SUPPLEMENT), Placebo supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04407754?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04407754 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Polycystic Ovary Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.